CONTACT  |  DONATE  |    
Accelerating the discovery of a cure for ALS.
NEWS

< Home






Prize4Life Video Premiere
Posted on: June 10, 2011

At our recent A Prize4Life Gala, we premiered a short video featuring some of the top minds in the ALS academic, clinical, and industry communities discussing the horrific nature of this disease, why it so desperately needs more funding and attention, and how Prize4Life is using its unique and powerful model to catalyze breakthroughs and accelerate the development of treatments and a cure.

 

 

Our deepest thanks to all of the individuals who shared their time and thoughts with us in order to produce this video. Participants, in order of appearance, include:

Dr. Edward Kaye

Group Vice President of Clinical Research, Genzyme Corporation

Member, Prize4Life Scientific Advisory Board

 

Dr. Doug Kerr

Director of Neurology Research and Development, Biogen Idec

 

Dr. H. Robert Horvitz

Professor of Biology, Massachusetts Institute of Technology

Investigator, Howard Hughes Medical Institute

Nobel Prize Winner, 2002

 

Dr. Melanie Leitner

Chief Scientific Officer, Prize4Life

 

Dr. Howard Weiner

Principal Investigator, Brigham and Women's Hospital

 

Dr. Tom Maniatis

Chairman of the Department of Biochemistry and Molecular Biophysics, Columbia University College of Physicians and Surgeons

Member, Prize4Life Scientific Advisory Board

 

Dr. Oleg Butovsky

Research Fellow, Brigham and Women's Hospital

 

Dr. Robert Brown

Chair of Neurology, UMass Medical School and UMass Memorial Medical Center

Member, Prize4Life Scientific Advisory Board

 

Dr. Craig Mello

Investigator, Howard Hughes Medical Institute

Co-Director, RNA Therapeutics Institute

Blais University Chair in Molecular Medicine, UMass Medical School

Nobel Prize Winner, 2006

 

Dr. Holger Patzke

Principal Scientist, EnVivo Pharmaceuticals

 

Dr. Vicki Sato

Professor, Harvard Business School

Former President, Vertex Pharmaceuticals

Member, Prize4Life Board of Directors

 

Dr. Seward Rutkove

Chief of the Division of Neuromuscular Disease, Beth Israel Deaconess Medical Center

$1M ALS Biomarker Prize Winner